Answers are grounded in this paper and cite their sources.
The assessment of toxicological concentrations of possible genotoxic contaminants in drug substances was regarded as an important and challenging discipline. The International Conference and Harmonization (ICH) recommended that most pharmaceutical products be allowed to include 1.5 μg/day of a genotoxic contaminant. The goal of this study was to develop a quick and accurate method for measuring potential genotoxic impurities (PGIs) in SGLT2 inhibitors. The chromatographic conditions were appropriately optimized with the columns to achieve a decent separation and response of each impurities peak. According to International conference of Harmonization (ICH) criteria for the quantification of each impurity, method validation for LC-MS was carried out regarding specificity, the limit of detection (LOD), the limit of quantification (LOQ), linearity, accuracy (recovery), precision, and solution stability. Correlation observed in the accuracy during method validation hence method can be considered linear and accurate and can be used for testing of genotoxic impurity in SGLT2 inhibitors.
No takes yet. Share an insight, caveat, or question.
Akhila et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: